{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:26Z","timestamp":1761624746892,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.arbr.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T04:14:24Z","timestamp":1635740064000},"page":"671-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bronchiectasis and Eosinophils"],"prefix":"10.1016","volume":"57","author":[{"given":"Miguel \u00c1ngel","family":"Mart\u00ednez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbr.2021.08.001_bib0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.arbres.2018.09.010","article-title":"Heterogeneity and complexity in bronchiectasis: a pending challenge","volume":"55","author":"Martinez-Garcia","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.arbres.2019.02.024","article-title":"Bronchiectasis: a complex, heterogeneous disease","volume":"55","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0175","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.rmed.2007.06.028","article-title":"Dissociation of lung function, dyspnea ratings and pulmonary extension in bronchiectasis","volume":"101","author":"Martinez-Garcia","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.arbr.2021.08.001_bib0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.arbres.2016.12.003","article-title":"Etiology of bronchiectasis in a cohort of 2047 patients. An analysis of the Spanish Historical Bronchiectasis Registry","volume":"53","author":"Olveira","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0185","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00069007","article-title":"Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms","volume":"31","author":"Fuschillo","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbr.2021.08.001_bib0190","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.4049\/jimmunol.142.12.4428","article-title":"Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein","volume":"142","author":"Lehrer","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.arbres.2019.09.015","article-title":"Plasma eosinophil count and patient-centered events in chronic obstructive pulmonary disease in real-life clinical practice","volume":"56","author":"Golpe","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0200","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.3390\/ijerph18168431","article-title":"Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: the role of eosinophils in disease severity","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.arbr.2021.08.001_bib0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbres.2019.12.021","article-title":"RIBRON: The Spanish Online Bronchiectasis Registry. Characterization of the first 1912 patients","volume":"57","author":"Martinez-Garc\u00eda","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.arbres.2019.05.001","article-title":"Bronchiectasis: when the published scientific evidence proves insufficient","volume":"55","author":"Martinez-Garcia","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0215","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.arbres.2018.10.012","article-title":"Bronchiectasis guidelines \u2013 recommendations into practice","volume":"55","author":"Redondo","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","article-title":"Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0230","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society Guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbr.2021.08.001_bib0235","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbres.2020.04.023","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"de la Rosa Carrillo","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01896-2018","article-title":"Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis","volume":"54","author":"Henkle","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbr.2021.08.001_bib0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.arbres.2019.06.001","article-title":"Global strategy for the diagnosis management, and prevention of chronic obstructive lung disease 2019 report: future challenges","volume":"56","author":"L\u00f3pez-Campos","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0250","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.arbres.2019.09.002","article-title":"Personalized medicine in chronic obstructive pulmonary disease: how close are we?","volume":"56","author":"D\u00edaz L\u00f3pez","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0255","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.arbr.2019.09.005","article-title":"Adjusting the level of intervention in patients with chronic obstructive pulmonary disease according to the risk stratification proposed by the Spanish COPD Guidelines (GesEPOC) Version 2017","volume":"56","author":"Iribarren","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arbres.2018.07.026","article-title":"The BIOMEPOC Project: personalized biomarkers and clinical profiles in chronic obstructive pulmonary disease","volume":"55","author":"Gea","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0265","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.arbres.2019.02.004","article-title":"Acute exacerbation according to GOLD 2017 categories in patients with chronic obstructive pulmonary disease","volume":"55","author":"Kim","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0270","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arbr.2019.02.011","article-title":"Patients with chronic obstructive pulmonary disease exacerbations: recommendations for diagnosis treatment and care","volume":"55","author":"Navarrete","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.arbr.2018.08.003","article-title":"Bronchiectasis in COPD and asthma more than just a coincidence","volume":"55","author":"Padilla","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.arbres.2018.07.002","article-title":"Prognostic value of frequent exacerbations in bronchiectasis: the relationship with disease severity","volume":"55","author":"Mart\u00ednez-Garc\u00eda","year":"2019","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0285","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.arbres.2019.12.017","article-title":"C-reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. data from the Spanish Registry of Bronchiectasis (RIBRON)","volume":"57","author":"Posadas","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0290","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arbres.2019.12.010","article-title":"The roles of bacteria and viruses in bronchiectasis exacerbation: a prospective study","volume":"56","author":"Chen","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0295","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.arbres.2020.06.005","article-title":"Repeteability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. A post hoc analysis of a randomized clinical trial","volume":"56","author":"Martinez-Garcia","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbr.2021.08.001_bib0300","doi-asserted-by":"crossref","first-page":"106127","DOI":"10.1016\/j.rmed.2020.106127","article-title":"Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia; pooled post-hoc analysis of 2 randomized clinical trials","volume":"172","author":"Martinez-Garcia","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.arbr.2021.08.001_bib0305","doi-asserted-by":"crossref","first-page":"2000453","DOI":"10.1183\/13993003.00453-2020","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbr.2021.08.001_bib0310","doi-asserted-by":"crossref","first-page":"2002210","DOI":"10.1183\/13993003.02210-2020","article-title":"Blood eosinophils do not predict inhaled budesonide response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbr.2021.08.001_bib0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JAA.S196200","article-title":"Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab","volume":"12","author":"Carpagnano","year":"2019","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.arbr.2021.08.001_bib0320","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","volume":"55","author":"Rademacher","year":"2020","journal-title":"Eur Respir J"}],"container-title":["Archivos de Bronconeumolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157921292100361X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157921292100361X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:07:20Z","timestamp":1761624440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157921292100361X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S157921292100361X"],"URL":"https:\/\/doi.org\/10.1016\/j.arbr.2021.08.001","relation":{},"ISSN":["1579-2129"],"issn-type":[{"type":"print","value":"1579-2129"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis and Eosinophils","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbr.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}